Treatment of Bacillary Dysentery with Erythromacin Estolate (Ilosone)

DOI Web Site 1 Citations

Bibliographic Information

Other Title
  • 細菌性赤痢のエリスロマイシンエストレート (アイロゾン) による治驗
  • サイキンセイ セキリ ノ エリスロマイシンエストレート アイロゾン ニ ヨル チケン

Search this article

Abstract

The effect of Erythromycin estolate was observed in 200 patients with bacillary dysentery and following results were obtained.<BR>1) Clinical effects of the drug was not so remarkable. For example, the duration of diarrhea was not markedly reduced.<BR>2) The bacilli of dysentery in feces disappeared within about 1.5 days from the beginning of admission. Reappearance was observed in 11%.<BR>3) Side effects were as follows: gastrointestinal symptoms e.g. anorexia, nausea, abdominal distress in 14% and subclinical disturbances of the liver in some cases. Neither jaundice nor exanthem was observed.<BR>Our observation clearly demonstrates that Erythromycin estolate (Ilosone) is very usefull in the treatment of the bacillary dysentery, especially in mild or symptomless cases and carriers, though clinical effects were not so apparent.

Journal

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top